The Latest Articles from Streetwise Reports


News Update

Animal Feed Supplement Maker Expands Asia Footprint

News Update
  ()
Avivagen receives new orders from two eastern countries for its product. read more >

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

  ()
Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. read more >
News Update

Healthcare Firm Expands Telemedicine App to Ontario as Coronavirus Concerns Accelerate Demand

News Update
  ()
CloudMD reported that it has launched its telemedicine app in Ontario as coronavirus concerns have greatly increased the need for digital healthcare. read more >

Three COVID-19 Patients Treated with PLX Cells

Research Report
  ()
Two programs, one new and the other ongoing, involving Pluristem Therapeutics' regenerative products are reviewed in a Dawson James report. read more >

Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick

  ()
Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. read more >

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

  ()
Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. read more >
News Update

Cannabis Beverage and Edibles Supplier Signs Agreements with Manitoba and Saskatchewan

News Update
  ()
Sproutly Canada's subsidiary company Toronto Herbal Remedies has entered into a cannabis supply contract with Manitoba and Saskatchewan provinces to carry the firm's CALIBER brand indoor-grown dried flower products. read more >

Abbott Labs Launches Point-of-Care Diagnostic Tool that Can Detect COVID-19 in 5 Minutes

  ()
Shares of Abbott Laboratories opened 11% higher after the company reported that its ID NOW™ molecular point-of-care test to detect novel coronavirus will be available starting this week with plans to quickly ramp up production to deliver 50,000 tests per day. read more >

Eton Pharma Shares Climb 20% After Firm Secures US Rights for Pediatric Kidney Disease Drug

  ()
Shares of Eton Pharmaceuticals traded higher after the company reported that it has acquired U.S. marketing rights to pediatric orphan drug Alkindi® Sprinkle from Diurnal Group Plc. read more >
News Update

Drone Firm Chosen to Integrate Breakthrough Health Diagnosis Technology in Fight Against Coronavirus

  ()
Draganfly and its partners aim to rapidly deploy the groundbreaking technology so it can help combat COVID-19. read more >

Coty Shares Rise 30% After Starting Production of Gel for Hand Sanitizer Use

  ()
Shares of Coty traded higher after the company reported that it has commenced production of hydro-alcoholic gel for use as hand sanitizer to help combat the COVID-19 virus. read more >

Coronavirus Propels Telemedicine into the Spotlight

Contributed Opinion
  ()
McAlinden Research Partners takes a look at how telemedicine companies are positioned to profit both during and in the wake of the current pandemic, and offers a couple of options for investors. read more >
News Update

Maker of Antibiotic-Free Animal Supplement Lands First Order from Mexico

News Update
  ()
This new market is a significant one for Avivagen. read more >
News Update

Inhaled Nitric Oxide Being Tested as COVID-19 Treatment

News Update
  ()
Nu-Med Plus has two collaborative, Phase 2 clinical trials in progress, which it is diligently monitoring. read more >
News Update

Digital Health Firm Expands Its Mobile Platform to Four U.S. States

News Update
  ()
Reliq Health Technologies has entered into an agreement with MedTech Evolutions to provide its iUGO Care platform to over 27,000 patients in Alabama, Illinois, Mississippi and Tennessee. read more >
News Update

Canadian Logistics Firm Partners with Cannabis Companies

News Update
  ()
ParcelPal Technology continues expanding its reach into this growing market. read more >
News Update

Cannabis Firm Outlines Business Strategies for Custom Formulations

News Update
  ()
The company plans to accelerate the path to greater revenues and profitability. read more >

Biopharma to Accelerate Alzheimer Trial Completion

Research Report
  ()
The upcoming catalysts for Axsome Therapeutics and the effects of COVID-19 on its clinical activities are discussed in an H.C. Wainwright & Co. report. read more >

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal

  ()
Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. read more >
News Update

Logistics Company Gears Up Operations to Meet Increased COVID-19 Related Demand

News Update
  ()
ParcelPal Technology hired 50 new staff members in order to guarantee that service levels can be maintained without disruption to clients and vendors as the firm faces major increases in demand. read more >

Blockchain Holdings Acquires COVID-19 Quarantine Tracker Already in Use in Hong Kong

  ()
The company anticipates adoption of the TRACEsafe system by other countries soon. read more >

Blockchain Holdings Acquires Monitoring System, Successfully Implemented in Hong Kong, to Help Stem the Spread of COVID-19

Contributed Opinion
  ()
Simple, non-invasive hospital-style wrist band and SaaS technology could spell explosive growth for company as the world combats the coronavirus. read more >
News Update

Telehealth Software Firm Responds to Client Needs Around COVID-19

News Update
  ()
Reliq Health Technologies explains how it is helping protect its customers' elderly patients. read more >

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 Treatment

  ()
Shares of Bellerophon Therapeutics traded more than 400% higher after the firm reported that the U.S. FDA granted emergency expanded access for its INOpulse® nitric oxide delivery system device for use in treatment of COVID-19 virus. read more >
News Update

Firm to Accelerate Launch of Immune Booster for Humans

News Update
  ()
Avivagen hires a firm to assist with the product's commercial debut. read more >
Showing Results: 1 to 25 of 218 Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts